information

Whoever comes in this website may find a hint

Phage therapy is influenced by:

Phage therapy is influenced by:

Country :
the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view

From Wikipedia


If the target host* of a phage therapy treatment is not
an animal the term "
biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".

"In silico"

From:"Genomics,Proteomics and Clinical Bacteriology", N.Woodford and Alan P.Johnson

Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.

Wednesday, 29 October 2014

Now we all write about Phage therapy but where are the results?

The main target where there is a good chance of success for  phage therapy  is the skin  infection because  in this situation  there are few  adverse factors.


From
ClinicalTrials.gov


 



 The reasons are:
-easy medication
-easy check
- use of one Lytic Phage  or Phage cocktail
-direct contact with bacteria
-no antibodies
- easy to remove phage by washing
-et cetera


  In my old web site there is this document  from :



 
that now is unobtainable.





Comment:

 First we must   test  phage therapy in this  clinical area (and after in the others)


We must consolidate the theory but also to put it into the practice

It is  unsatisfactory to write  on Phage therapy only for publications

Why the PhagoBurn project is started ?   For the same reasons described above .